134 related articles for article (PubMed ID: 8206214)
1. Multiple dopamine receptors: relevance for neurodegenerative disorders.
Strange PG
Biochem Soc Trans; 1994 Feb; 22(1):155-9. PubMed ID: 8206214
[No Abstract] [Full Text] [Related]
2. Non-invasive in vivo imaging of transplant function.
Brooks DJ; Piccini P
Prog Brain Res; 2000; 127():321-32. PubMed ID: 11142033
[No Abstract] [Full Text] [Related]
3. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
Ostergaard K; Sunde NA; Dupont E
Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
[No Abstract] [Full Text] [Related]
4. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
[TBL] [Abstract][Full Text] [Related]
5. Nondopaminergic neurons in Parkinson's disease.
Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
[No Abstract] [Full Text] [Related]
6. PET measurements of dopaminergic pathways in the brain.
Perlmutter JS; Moerlein SM
Q J Nucl Med; 1999 Jun; 43(2):140-54. PubMed ID: 10429509
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines and neurologic diseases (second of two parts).
Moskowitz MA; Wurtman RJ
N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
[No Abstract] [Full Text] [Related]
9. Brain neurotransmitters and neuropeptides in Parkinson's disease.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
[TBL] [Abstract][Full Text] [Related]
10. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
11. Medications for Parkinson's disease.
Whitney CM
Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
[No Abstract] [Full Text] [Related]
12. Neurochemical anatomy of movement disorders.
Young AB; Penney JB
Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptors set the pattern of activity generated in subthalamic neurons.
Baufreton J; Zhu ZT; Garret M; Bioulac B; Johnson SW; Taupignon AI
FASEB J; 2005 Nov; 19(13):1771-7. PubMed ID: 16260646
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
15. Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2002 Mar; 109(3):239-49. PubMed ID: 11956948
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
Brücke T; Podreka I; Angelberger P; Wenger S; Topitz A; Küfferle B; Müller C; Deecke L
J Cereb Blood Flow Metab; 1991 Mar; 11(2):220-8. PubMed ID: 1671782
[TBL] [Abstract][Full Text] [Related]
17. Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease.
Morgan DG; May PC; Finch CE
J Am Geriatr Soc; 1987 Apr; 35(4):334-45. PubMed ID: 3549845
[TBL] [Abstract][Full Text] [Related]
18. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
[No Abstract] [Full Text] [Related]
19. Dopamine receptors in Parkinson's disease: imaging studies.
Stoessl AJ; de la Fuente-Fernández R
Adv Neurol; 2003; 91():65-71. PubMed ID: 12442664
[No Abstract] [Full Text] [Related]
20. [Diagnostic use of SPECT with visualization of dopamine transporters in Parkinson disease. The Danish Society of Neurology].
Løkkegaard A; Friberg L
Ugeskr Laeger; 2003 Mar; 165(12):1247. PubMed ID: 12701297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
